โ Scribed by John Y.M. Koo, Mark G. Lebwohl, Chai Sue Lee
No coin nor oath required. For personal study only.
Written by experts in the dermatology field, the new Third Edition of Moderate-to-Severe Psoriasis discusses the current use of biologics and new pharmacologic and phototherapy treatments for moderate-to-severe psoriasis. With 80 high quality color figures and full color throughout, this stand-alone text emphasizes safe and effective treatments for the psoriasis patient that are perfect for the dermatologist in daily practice.New to the Third Edition:the addition of chapters on the use of infliximab, efalizumab, and Humera, as well as the latest status of clinical trialsthe most up-to-date phototherapy and laser treatment modalitiesstronger coverage of psoriatic arthritis
๐ SIMILAR VOLUMES
<P>Written by experts in the dermatology field, this new fourth edition of <I><STRONG>Moderate-to-Severe Psoriasis</STRONG></I> discusses the current use of biologics and other pharmacologic and phototherapy treatments for moderate-to-severe psoriasis. Illustrated with high quality color figures, th
<P>Written by experts in the dermatology field, this new fourth edition of <I><STRONG>Moderate-to-Severe Psoriasis</STRONG></I> discusses the current use of biologics and other pharmacologic and phototherapy treatments for moderate-to-severe psoriasis. Illustrated with high quality color figures, th
This handbook features updated chapters discussing the latest and most commonly prescribed therapies for patients with moderate-to-severe psoriasis. Topics include the management of paediatric patients and patients with psoriatic arthritis
Univ. of California, Irvine. Text provides state-of-the-art clinical guidelines for the management of moderate-to-severe psoriasis. Includes discussions about topical treatments, UVB phototherapy, use of methotrexate, pediatric psoriasis, and recent research. Previous edition: c1993.